vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Snail, Inc. (SNAL). Click either name above to swap in a different company.

AbCellera Biologics Inc. is the larger business by last-quarter revenue ($44.9M vs $25.1M, roughly 1.8× Snail, Inc.). Snail, Inc. runs the higher net margin — -3.4% vs -19.9%, a 16.5% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs -4.2%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 33.4%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....

ABCL vs SNAL — Head-to-Head

Bigger by revenue
ABCL
ABCL
1.8× larger
ABCL
$44.9M
$25.1M
SNAL
Growing faster (revenue YoY)
ABCL
ABCL
+792.6% gap
ABCL
788.4%
-4.2%
SNAL
Higher net margin
SNAL
SNAL
16.5% more per $
SNAL
-3.4%
-19.9%
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
33.4%
SNAL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
SNAL
SNAL
Revenue
$44.9M
$25.1M
Net Profit
$-8.9M
$-862.2K
Gross Margin
38.3%
Operating Margin
-63.7%
-6.0%
Net Margin
-19.9%
-3.4%
Revenue YoY
788.4%
-4.2%
Net Profit YoY
73.9%
-177.0%
EPS (diluted)
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
SNAL
SNAL
Q4 25
$44.9M
$25.1M
Q3 25
$9.0M
$13.8M
Q2 25
$17.1M
$22.2M
Q1 25
$4.2M
$20.1M
Q4 24
$5.0M
$26.2M
Q3 24
$6.5M
$22.5M
Q2 24
$7.3M
$21.6M
Q1 24
$10.0M
$14.1M
Net Profit
ABCL
ABCL
SNAL
SNAL
Q4 25
$-8.9M
$-862.2K
Q3 25
$-57.1M
$-7.9M
Q2 25
$-34.7M
$-16.6M
Q1 25
$-45.6M
$-1.9M
Q4 24
$1.1M
Q3 24
$-51.1M
$235.1K
Q2 24
$-36.9M
$2.3M
Q1 24
$-40.6M
$-1.8M
Gross Margin
ABCL
ABCL
SNAL
SNAL
Q4 25
38.3%
Q3 25
0.1%
Q2 25
31.3%
Q1 25
29.1%
Q4 24
43.3%
Q3 24
38.6%
Q2 24
37.5%
Q1 24
14.7%
Operating Margin
ABCL
ABCL
SNAL
SNAL
Q4 25
-63.7%
-6.0%
Q3 25
-851.8%
-71.3%
Q2 25
-290.2%
-8.2%
Q1 25
-1479.6%
-20.4%
Q4 24
11.5%
Q3 24
-1439.4%
1.8%
Q2 24
-1276.2%
12.4%
Q1 24
-551.5%
-15.6%
Net Margin
ABCL
ABCL
SNAL
SNAL
Q4 25
-19.9%
-3.4%
Q3 25
-637.8%
-56.9%
Q2 25
-203.3%
-74.7%
Q1 25
-1077.2%
-9.7%
Q4 24
4.3%
Q3 24
-785.4%
1.0%
Q2 24
-504.3%
10.4%
Q1 24
-408.0%
-12.6%
EPS (diluted)
ABCL
ABCL
SNAL
SNAL
Q4 25
$-0.03
Q3 25
$-0.19
Q2 25
$-0.12
$-0.44
Q1 25
$-0.15
$-0.06
Q4 24
$0.03
Q3 24
$-0.17
$0.01
Q2 24
$-0.13
$0.06
Q1 24
$-0.14
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
SNAL
SNAL
Cash + ST InvestmentsLiquidity on hand
$128.5M
$8.6M
Total DebtLower is stronger
$14.6M
Stockholders' EquityBook value
$966.9M
$-16.4M
Total Assets
$1.4B
$59.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
SNAL
SNAL
Q4 25
$128.5M
$8.6M
Q3 25
$83.2M
$12.3M
Q2 25
$92.4M
$7.9M
Q1 25
$159.3M
$9.4M
Q4 24
$156.3M
$7.3M
Q3 24
$126.6M
$10.6M
Q2 24
$148.3M
$15.5M
Q1 24
$123.6M
$16.1M
Total Debt
ABCL
ABCL
SNAL
SNAL
Q4 25
$14.6M
Q3 25
$10.5M
Q2 25
$11.8M
Q1 25
$9.0M
Q4 24
$5.7M
Q3 24
$5.7M
Q2 24
$5.8M
Q1 24
$6.5M
Stockholders' Equity
ABCL
ABCL
SNAL
SNAL
Q4 25
$966.9M
$-16.4M
Q3 25
$964.0M
$-15.6M
Q2 25
$1.0B
$-8.0M
Q1 25
$1.0B
$9.1M
Q4 24
$1.1B
$9.7M
Q3 24
$1.1B
$8.2M
Q2 24
$1.1B
$7.9M
Q1 24
$1.1B
$5.6M
Total Assets
ABCL
ABCL
SNAL
SNAL
Q4 25
$1.4B
$59.3M
Q3 25
$1.4B
$51.1M
Q2 25
$1.4B
$58.0M
Q1 25
$1.3B
$64.5M
Q4 24
$1.4B
$62.2M
Q3 24
$1.4B
$66.8M
Q2 24
$1.4B
$75.4M
Q1 24
$1.5B
$78.3M
Debt / Equity
ABCL
ABCL
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
0.99×
Q4 24
0.59×
Q3 24
0.70×
Q2 24
0.73×
Q1 24
1.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
SNAL
SNAL
Operating Cash FlowLast quarter
$-34.7M
$-5.3M
Free Cash FlowOCF − Capex
$-44.6M
FCF MarginFCF / Revenue
-99.4%
Capex IntensityCapex / Revenue
21.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-174.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
SNAL
SNAL
Q4 25
$-34.7M
$-5.3M
Q3 25
$-52.6M
$6.6M
Q2 25
$-32.4M
$-3.2M
Q1 25
$-11.6M
$764.5K
Q4 24
$-108.6M
$-3.6M
Q3 24
$-28.9M
$-5.0M
Q2 24
$-30.0M
$206.6K
Q1 24
$-41.7M
$6.8M
Free Cash Flow
ABCL
ABCL
SNAL
SNAL
Q4 25
$-44.6M
Q3 25
$-61.5M
Q2 25
$-45.8M
Q1 25
$-22.2M
Q4 24
$-187.0M
Q3 24
$-47.4M
Q2 24
$-50.1M
Q1 24
$-65.8M
FCF Margin
ABCL
ABCL
SNAL
SNAL
Q4 25
-99.4%
Q3 25
-687.0%
Q2 25
-267.9%
Q1 25
-524.0%
Q4 24
-3702.8%
Q3 24
-728.4%
Q2 24
-683.8%
Q1 24
-661.5%
Capex Intensity
ABCL
ABCL
SNAL
SNAL
Q4 25
21.9%
Q3 25
99.7%
Q2 25
78.2%
Q1 25
251.1%
Q4 24
1552.7%
Q3 24
284.6%
Q2 24
274.6%
Q1 24
242.5%
Cash Conversion
ABCL
ABCL
SNAL
SNAL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.21×
Q3 24
-21.05×
Q2 24
0.09×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

SNAL
SNAL

Pc$14.7M59%
Platform Three$5.2M21%
Platform Two$3.3M13%
Sales Channel Directly To Consumer Mobile Sale$1.6M6%

Related Comparisons